XML 35 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Net Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2020
Net Earnings (Loss) Per Share [Abstract]  
Net Earnings (Loss) Per Share (14) Net Earnings (Loss) Per Share:

The reconciliation of the net earnings (loss) per share calculation is as follows:

For the three months ended

For the nine months ended

September 30,

September 30,

($ in millions and shares in thousands, except per share amounts)

2020

2019

2020

2019

Net income (loss) used for basic and diluted earnings (loss)

per share:

Total basic net income (loss)

attributable to Frontier common shareholders

$

15 

$

(345)

$

(352)

$

(5,749)

Effect of loss related to dilutive stock units

-

-

-

-

Total diluted net income (loss)

attributable to Frontier common shareholders

$

15 

$

(345)

$

(352)

$

(5,749)

Basic earnings (loss) per share:

Total weighted average shares and unvested restricted stock

awards outstanding - basic

104,919 

105,372 

104,989 

105,375 

Less: Weighted average unvested restricted stock awards

(393)

(1,237)

(529)

(1,344)

Total weighted average shares outstanding - basic

104,526 

104,135 

104,460 

104,031 

Basic net earnings (loss) per share

attributable to Frontier common shareholders

$

0.14 

$

(3.31)

$

(3.37)

$

(55.26)

Diluted earnings (loss) per share:

Total weighted average shares outstanding - basic

104,526 

104,135 

104,460 

104,031 

Effect of dilutive stock units

340 

-

-

-

Total weighted average shares outstanding - diluted

104,866 

104,135 

104,460 

104,031 

Diluted net earnings (loss) per share

attributable to Frontier common shareholders

$

0.14 

$

(3.31)

$

(3.37)

$

(55.26)

In calculating diluted net earnings (loss) per common share for the nine months ended September 30, 2020 and the three and nine months ended September 30, 2019, the effect of all common stock equivalents is excluded from the computation as the effect would be antidilutive.

Stock Options

For the three and nine months ended September 30, 2020 there were no outstanding stock options. As of September 30, 2019, previously granted options to purchase 1,334 shares issuable under employee compensation plans were excluded from the computation of diluted earnings (loss) per share (EPS) for those periods because the exercise prices were greater than the average market price of our common stock and, therefore, the effect would be antidilutive. These options expired on July 6, 2020.

Stock Units

At each of September 30, 2020 and September 30, 2019, we had 339,544 stock units issued under the Non-Employee Directors’ Deferred Fee Equity Plan (Deferred Fee Plan), the Non-Employee Directors’ Equity Incentive Plan (Directors’ Equity Plan), the 2013 Equity Incentive Plan and the 2017 Equity Incentive Plan. These securities have not been included in the diluted EPS calculation for the nine months ended September 30, 2020 and the three and nine months ended September 30, 2019 because their inclusion would have an antidilutive effect. Compensation costs associated with the issuance of stock units were less than $1 million for each of the nine months ended September 30, 2020 and 2019, respectively. As of June 2019, no further stock units have been issued to Non-Employee Directors.